By expenditures
| Name | Title | Type |
|---|---|---|
| Gail Rengiil | Director Of Bureau Of National Treasury | Auditee |
| Rizalito Paglingayen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 402685 | 2023 | 2026-05-31 | ERNST & YOUNG (CNMI) INC | $23.34M |
| 370385 | 2022 | 2025-10-02 | Ernst & Young (cnmi) INC | $43.84M |
| 331185 | 2021 | 2024-12-05 | Ernst & Young (cnmi) INC | $38.07M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 402685 | 2023 | 2026-05-31 | 1216208 | 2023-016 | Material Weakness | Yes | I |
| 402685 | 2023 | 2026-05-31 | 1216207 | 2023-015 | Material Weakness | Yes | N |
| 402685 | 2023 | 2026-05-31 | 1216206 | 2023-014 | Material Weakness | Yes | I |
| 402685 | 2023 | 2026-05-31 | 1216205 | 2023-013 | Material Weakness | Yes | C |
| 402685 | 2023 | 2026-05-31 | 1216204 | 2023-012 | Material Weakness | Yes | I |
| 402685 | 2023 | 2026-05-31 | 1216203 | 2023-011 | Material Weakness | Yes | I |
| 402685 | 2023 | 2026-05-31 | 1216202 | 2023-010 | Material Weakness | Yes | N |
| 370385 | 2022 | 2025-10-02 | 1159826 | 2022-010 | Material Weakness | Yes | N |
| 370385 | 2022 | 2025-10-02 | 1159825 | 2022-009 | Material Weakness | Yes | I |
| 370385 | 2022 | 2025-10-02 | 1159824 | 2022-008 | Material Weakness | Yes | I |
| 370385 | 2022 | 2025-10-02 | 1159823 | 2022-007 | Material Weakness | Yes | L |
| 370385 | 2022 | 2025-10-02 | 1159822 | 2022-006 | Material Weakness | Yes | E |
| 370385 | 2022 | 2025-10-02 | 1159821 | 2022-005 | Material Weakness | Yes | M |
| 331185 | 2021 | 2024-12-05 | 1089684 | 2021-008 | Significant Deficiency | - | P |
| 331185 | 2021 | 2024-12-05 | 1089683 | 2021-007 | Material Weakness | Yes | N |
| 331185 | 2021 | 2024-12-05 | 1089682 | 2021-006 | Significant Deficiency | - | N |
| 331185 | 2021 | 2024-12-05 | 1089681 | 2021-005 | Material Weakness | - | L |
| 331185 | 2021 | 2024-12-05 | 1089680 | 2021-004 | Significant Deficiency | - | E |
| 331185 | 2021 | 2024-12-05 | 1089679 | 2021-003 | Material Weakness | - | A |
| 331185 | 2021 | 2024-12-05 | 513242 | 2021-008 | Significant Deficiency | - | P |
| 331185 | 2021 | 2024-12-05 | 513241 | 2021-007 | Material Weakness | Yes | N |
| 331185 | 2021 | 2024-12-05 | 513240 | 2021-006 | Significant Deficiency | - | N |
| 331185 | 2021 | 2024-12-05 | 513239 | 2021-005 | Material Weakness | - | L |
| 331185 | 2021 | 2024-12-05 | 513238 | 2021-004 | Significant Deficiency | - | E |
| 331185 | 2021 | 2024-12-05 | 513237 | 2021-003 | Material Weakness | - | A |